Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2022
Involvement of molecular chaperone in protein-misfolding brain diseases.
СтатьяОбзорНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Wankhede Nitu L, Kale Mayur B, Upaganlawar Aman B, Taksande Brijesh G, Umekar Milind J, Behl Tapan, Abdellatif Ahmed A H, Bhaskaran Prasanna Mohana, Dachani Sudarshan Reddy, Sehgal Aayush, Singh Sukhbir, Sharma Neelam, Makeen Hafiz A, Albratty Mohammed, Dailah Hamed Ghaleb, Bhatia Saurabh, Al-Harrasi Ahmed, Bungau Simona
Аннотация
Protein misfolding causes aggregation and build-up in a variety of brain diseases. There are numeral molecules that are linked with the protein homeostasis mechanism. Molecular chaperones are one of such molecules that are responsible for protection against protein misfolded and aggregation-induced neurotoxicity. Many studies have explored the participation of molecular chaperones in Parkinson's disease, Alzheimer's disease, Amyotrophic lateral sclerosis, and Huntington's diseases. In this review, we highlighted the constructive role of molecular chaperones in neurological diseases characterized by protein misfolding and aggregation and their capability to control aberrant protein interactions at an early stage thus successfully suppressing pathogenic cascades. A comprehensive understanding of the protein misfolding associated with brain diseases and the molecular basis of involvement of chaperone against aggregation-induced cellular stress might lead to the progress of new therapeutic intrusion-related to protein misfolding and aggregation.